Jacobin | NicePNG
Teaming up with Big Pharma and Wall Street, universities are profiting by fighting government efforts to curtail soaring drug prices. A case in point: UCLA has reaped more than a billion dollars from its development of Xtandi, a lifesaving cancer drug.